BayBio Chairman Emeritus
Venture Partner at Clarus Ventures

William D. Young is currently a Venture Partner at Clarus Ventures in South San Francisco, CA. He is the former Chairman of the Board and Chief Executive Officer of Monogram Biosciences a pioneer in developing and marketing products for personalized medicine. Monogram was acquired by LabCorp in August of 2009. He served as Chief Executive Officer from November 1999 and as the Chairman of the Board from May 1999. From March 1997 to October 1999, Mr. Young was Chief Operating Officer of Genentech, Inc., the worlds most successful biotechnology company. As COO at Genentech, Mr. Young was responsible for all of the company's development, operations and commercial functions. Mr. Young joined Genentech in 1980 as Director of Manufacturing and Process Sciences and held various executive positions prior to becoming COO. Prior to joining Genentech, Mr. Young was employed by Eli Lilly and Company for 14 years. Mr. Young is Chairman of the Board of Directors of Biogen IDEC, Inc., a member of the Board of Theravance, Inc and Executive Chairman of NanoString, a private company based in Seattle, as well as a former chairman and current member of the board of BayBio. He received his bachelor's degree in chemical engineering from Purdue University, his MBA from Indiana University and an honorary doctorate in engineering from Purdue University. In 1993 he was elected to the National Academy of Engineering for his contributions to Biotechnology..